Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kevin Kelly

Showing results (141-150 of 253) with videos related to

Pageof 26
Sort By:
Life Science Alliance|August 17, 2019
GRP78 regulates CD44v membrane homeostasis and cell spreading in tamoxifen-resistant breast cancerChun-Chih Tseng, Ramunas Stanciauskas, Pu Zhang, et al.
Journal of Geriatric Oncology|March 23, 2020
Relationship between polypharmacy and inpatient hospitalization among older adults with cancer treated with intravenous chemotherapyGrace Lu-Yao, Ginah Nightingale, Nikita Nikita, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 23, 2014
Updated prognostic model for predicting overall survival in first-line chemotherapy for patients with metastatic castration-resistant prostate cancerSusan Halabi, Chen-Yen Lin, W Kevin Kelly, et al.
Sleep|July 25, 2016
Prevalence, Correlates, and Predictors of Insomnia in the US Army prior to DeploymentDaniel J Taylor, Kristi E Pruiksma, Willie J Hale, et al.
Contemporary Clinical Trials|December 25, 2022
Predictors of consenting to participate in a clinical trial among urban cancer patientsRussell K McIntire, Scott W Keith, Thomas Nowlan, et al.
The Lancet. Oncology|October 19, 2007
Addition of estramustine to chemotherapy and survival of patients with castration-refractory prostate cancer: a meta-analysis of individual patient dataKarim Fizazi, Aurelie Le Maitre, Gary Hudes, et al.
Human Mutation|June 26, 2019
Functional interrogation of Lynch syndrome-associated MSH2 missense variants via CRISPR-Cas9 gene editing in human embryonic stem cellsAbhijit Rath, Akriti Mishra, Victoria Duque Ferreira, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 26, 2008
Phase I trial of the prostate-specific membrane antigen-directed immunoconjugate MLN2704 in patients with progressive metastatic castration-resistant prostate cancerMatthew D Galsky, Mario Eisenberger, Sandra Moore-Cooper, et al.
Cancer|October 30, 2003
Clinical experience with intravenous estramustine phosphate, paclitaxel, and carboplatin in patients with castrate, metastatic prostate adenocarcinomaDavid B Solit, Michael Morris, Susan Slovin, et al.
Clinical Lymphoma, Myeloma & Leukemia|July 23, 2015
Persistent Disparities Among Patients With T-Cell Non-Hodgkin Lymphomas and B-Cell Diffuse Large Cell Lymphomas Over 40 Years: A SEER Database ReviewJennifer A Crozier, Taimur Sher, Dongyun Yang, et al.
Pageof 26

Showing results (141-150 of 253) with videos related to

Sort By:
Pageof 26
Life Science Alliance|August 17, 2019
GRP78 regulates CD44v membrane homeostasis and cell spreading in tamoxifen-resistant breast cancerChun-Chih Tseng, Ramunas Stanciauskas, Pu Zhang, et al.
Journal of Geriatric Oncology|March 23, 2020
Relationship between polypharmacy and inpatient hospitalization among older adults with cancer treated with intravenous chemotherapyGrace Lu-Yao, Ginah Nightingale, Nikita Nikita, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 23, 2014
Updated prognostic model for predicting overall survival in first-line chemotherapy for patients with metastatic castration-resistant prostate cancerSusan Halabi, Chen-Yen Lin, W Kevin Kelly, et al.
Sleep|July 25, 2016
Prevalence, Correlates, and Predictors of Insomnia in the US Army prior to DeploymentDaniel J Taylor, Kristi E Pruiksma, Willie J Hale, et al.
Contemporary Clinical Trials|December 25, 2022
Predictors of consenting to participate in a clinical trial among urban cancer patientsRussell K McIntire, Scott W Keith, Thomas Nowlan, et al.
The Lancet. Oncology|October 19, 2007
Addition of estramustine to chemotherapy and survival of patients with castration-refractory prostate cancer: a meta-analysis of individual patient dataKarim Fizazi, Aurelie Le Maitre, Gary Hudes, et al.
Human Mutation|June 26, 2019
Functional interrogation of Lynch syndrome-associated MSH2 missense variants via CRISPR-Cas9 gene editing in human embryonic stem cellsAbhijit Rath, Akriti Mishra, Victoria Duque Ferreira, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 26, 2008
Phase I trial of the prostate-specific membrane antigen-directed immunoconjugate MLN2704 in patients with progressive metastatic castration-resistant prostate cancerMatthew D Galsky, Mario Eisenberger, Sandra Moore-Cooper, et al.
Cancer|October 30, 2003
Clinical experience with intravenous estramustine phosphate, paclitaxel, and carboplatin in patients with castrate, metastatic prostate adenocarcinomaDavid B Solit, Michael Morris, Susan Slovin, et al.
Clinical Lymphoma, Myeloma & Leukemia|July 23, 2015
Persistent Disparities Among Patients With T-Cell Non-Hodgkin Lymphomas and B-Cell Diffuse Large Cell Lymphomas Over 40 Years: A SEER Database ReviewJennifer A Crozier, Taimur Sher, Dongyun Yang, et al.
Pageof 26